Intl. Biotechnology Trust PLC New Research
November 29 2016 - 11:29AM
RNS Non-Regulatory
TIDMIBT
Intl. Biotechnology Trust PLC
29 November 2016
International Biotechnology Trust plc: New research from
Investment Trust Intelligence
International Biotechnology Trust aims to deliver geared capital
growth over the long term and - as of this year - income, from a
diversified portfolio of small, medium and large biotech and life
sciences companies, the vast majority of them based in the United
States, with a smaller weighting in Europe.
In this research note, produced by the investment companies team
at Kepler Partners, we examine the portfolio in detail and talk to
fund managers Carl Harald Janson, Ailsa Craig and Kate Bingham
about their approach to stock selection, and the outlook for
biotech in a 'post-Clinton' world.
Click here to read the full report
Visit http://www.trustintelligence.co.uk for more high quality
independent investment trust research...
Not for distribution, directly or indirectly, in or into the
United States or any jurisdiction in which such distribution would
be unlawful.
About this service
Investment Trust Intelligence for private investors is not just
another news and research website. Our aim is to create a library
of high quality investment strategy research, fund analysis and
useful guides for private investors, all written in-house by
experienced analysts on the investment companies team at Kepler
Partners.
We are focused entirely on investment trusts, however we believe
that it helps to understand them better if they are placed on a
level playing field with OEICs, so you will see comparisons between
the two in these pages often.
Our content falls into three categories;
-- Investment strategy articles are designed to highlight
opportunities and developments which are of interest to investment
trust investors, positive or negative.
-- Fund research focuses on individual trusts, examining them in
detail to create a snapshot picture which you can use to decide
whether or not you want to invest in them.
-- Educational output is split into simple guides, designed to
help beginners understand how investment trusts work, and more
complex guides to sectors, regions and strategies which may be of
interest to investors.
We do not produce massive amounts of research. Our focus is on
quality, not quantity, so we are unlikely to publish more than four
or five articles in a given week. For this reason we recommend that
you join our mailing list, and we'll send you an email once a week
alerting you to what's new on the site. We won't sell your details,
and we won't spam you with useless updates.
How are we funded?
The vast majority of our research is produced on an independent
basis, however some of the research we produce is paid for by asset
management companies and investment trust boards, who want to raise
the profile of the trusts they are responsible for. If a trust has
paid us to produce research you will see that this is clearly
marked at the top of the page - where you will see the company's
logo on the top right. It will also say 'non-independent research'
underneath the name of the trust and you can click on this to learn
more about our relationship with that client.
We provide information, not advice
While we hope that you find the research we publish useful, and
we believe it will help you to make a more informed decision, but
we must of course stress that none of the research published here
constitutes a recommendation, or advice, and you should not think
that - just because we've published a report on a trust - we
believe that trust is a 'buy'. Please read our terms and
conditions.
If you want to manage your own investments we hope that this
website is a useful source of information which helps you to do
that, however if you are in any doubt, you should speak to a
financial adviser.
Pascal Dowling
Kepler Partners
pascal@keplerpartners.com
www.trustintelligence.co.uk
www.keplerpartners.com
29 November 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAAKCDDABDDADB
(END) Dow Jones Newswires
November 29, 2016 12:29 ET (17:29 GMT)
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From May 2024 to Jun 2024
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From Jun 2023 to Jun 2024